Looking again at Example 1 ( ERSM100040), researchers at the University of Utopia, Thomas and More, have been conducting research in a specialist area. The University decides to set up a spin-out company to develop the research further. It subscribes for 20 shares in the new company at par (£20). The University then transfers the IP as it stands into the spin-out company, with a proviso that it reverts to the University if further development is not fruitful. A further 30 shares are allocated to Thomas and More for which they pay £30. Each share is now worth £1,000. The relief for each researcher is shown in this computation:
| Value of shares received 15 x £1,000 | £15,000 | ||
| Payment for shares | £15 | ||
| Potential charge on undervalue | £14,985 | ||
| Spin-out relief – effect of IP | (£14,985) | ||
| Liability | nil |
The market value of Thomas's and More's shares when they acquire them is calculated disregarding the transfer of IP from Utopia University. Without this factor, there is no appreciable difference between the £30 paid for the shares and their market value and no charge to Income Tax or NICs arise under Part 7 of ITEPA.
Plato is a researcher at the Republic University. He sets up a
spin-out company himself, paying for an initial 50 x £1 shares
at market value of £50. Sometime later, after deciding that
the invention is not yet developed sufficiently to licence, the
University transfers the existing IP, worth £7,000, to the
spin-out and takes 20 x £1 shares. Plato waives any rights he
may have under an IP-sharing agreement with Republic University.
At this time there will be an increase in value of £100
each in the original shares. This would potentially render Plato
liable to a charge under Chapter 4 of Part 7 of ITEPA on 50 x
£100 = £5,000.
If, on or after 2 December 2004, there is either
the shares would be valued for Chapter 4 purposes as if the IP had not been transferred (i.e. shares would be treated as worth only a nominal £1 each) and there would therefore be no benefit to charge under Chapter 4.
Once the IP is in place, negotiations are concluded with venture
capitalists. They introduce funds of £50,000 and subscribe for
new shares at their market value. They consider this to be
£1,000 per share, taking account of the value of the company
complete with Plato, business plan, IP, and £50,000 funding.
So they receive 50 shares in return for their funds and the issued
share capital of the spin-out company is 120 x £1 shares.
The increase in value of Plato’s shares to £1,000
each as a result of the funding support obtained will be a normal
commercial increase in value and will not therefore be chargeable
under Chapter 4 of Part 7 of ITEPA. The benefit has not been passed
to him by his employer as it was when the IP was transferred.